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Abstract
Myelin determines the conduction of neuronal signals along axonal connections in
networks of the brain. Loss of myelin integrity in neuronal circuits might result in cog-
nitive decline in Alzheimer's disease (AD). Recently, the ratio of T1-weighted by
T2-weighted MRI has been used as a proxy for myelin content in gray matter of the
cortex. With this approach, we investigated whether AD dementia patients show
lower cortical myelin content (i.e., a lower T1-w/T2-w ratio value). We selected
structural T1-w and T2-w MR images of 293 AD patients and 172 participants with
normal cognition (NC). T1-w/T2-w ratios were computed for the whole brain and
within 90 automated anatomical labeling atlas regions using SPM12, compared
between groups and correlated with the neuronal injury marker tau in cerebrospinal
fluid (CSF) and Mini Mental State Examination (MMSE). In contrast to our hypothesis,
AD patients showed higher whole brain T1-w/T2-w ratios than NC, and regionally in
31 anatomical areas (p < .0005; d = 0.21 to 0.48), predominantly in the inferior parie-
tal lobule, angular gyrus, anterior cingulate, and precuneus. Regional higher
T1-w/T2-w values were associated with higher CSF tau concentrations (p < .0005;
r = .16 to .22) and worse MMSE scores (p < .0005; r = −.16 to −.21). These higher
T1-w/T2-w values in AD seem to contradict previous pathological findings of demye-
lination and disconnectivity in AD. Future research should further investigate the bio-
logical processes reflected by increases in T1-w/T2-w values.
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1 | INTRODUCTION
Alzheimer's disease (AD), the most common cause of dementia, is charac-
terized by a progressive decline in cognition and is one of the major pub-
lic health challenges of the 21st century (Scheltens et al., 2016). AD is
pathologically defined by β-amyloid (Aβ) neuritic plaques, tau neurofibril-
lary tangles, and is associated with neuronal, axonal, and synaptic
degeneration (Braak & Braak, 1991; Selkoe, 2002). Myelin, the insulating
sheath surrounding neuronal axons, is vulnerable to AD pathology while
it is essential for efficient neuronal communication by fine-tuning con-
duction speed and synchronization, thereby affecting brain connectivity
(Nave & Werner, 2014; Timmler & Simons, 2019). A failure in cerebral
connectivity has been shown to interfere with healthy cognitive func-
tioning (Fornito, Zalesky, & Breakspear, 2015; Pievani, Filippini, Van Den
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Heuvel, Cappa, & Frisoni, 2014). In recent years, several proxy measures
of myelin content have been proposed, including quantitative magnetic
resonance imaging (MRI) techniques such as myelin water fraction
(MWF) (Laule et al., 2007) and quantitative susceptibility mapping (QSM)
(de Rochefort, Brown, Prince, & Wang, 2008). Moreover, diffusion tensor
imaging (DTI) has been used extensively to measure the myelin
integrity of large axonal fiber bundles over long distance white matter
(WM) networks, which are disrupted in AD (Chua, Wen, Slavin, &
Sachdev, 2008; Gao et al., 2014).
An alternative approach of determining regional variation in cortical
myelin content, the ratio of the signal intensity of the T1-weighted
(T1-w) and T2-weighted (T2-w) image, has been proposed (Glasser &
Van Essen, 2011). The T1-w/T2-w technique was developed to
parcellate the cerebral cortex from patterns of cortical myelination, and
have shown to closely correspond with histological measures of
myeloarchitecture (Glasser & Van Essen, 2011; Nieuwenhuys & Broere,
2017). Compared to other quantitative MRI contrasts, this technique has
the advantage that images can be acquired during routine clinical MR
examinations, with high signal-to-noise, and without complex modeling
of the MR signal (Heath, Hurley, Johansen-Berg, & Sampaio-Baptista,
2018). Along the life-span, the T1-w/T2-w myelin shows an inverted U
curve (Grydeland et al., 2019; Grydeland, Walhovd, Tamnes, Westlye, &
Fjell, 2013; Shafee, Buckner, & Fischl, 2015), following the maturation of
cortical regions throughout life. In addition, higher T1-w/T2-w ratios
have been associated with greater performance stability during a
processing speed task (Grydeland et al., 2013). In disorders with a strong
demyelinating component such as multiple sclerosis (MS), the
T1-w/T2-w ratio is lowered in pathologically vulnerable regions (Beer
et al., 2016; Nakamura, Chen, Ontaneda, Fox, & Trapp, 2017). However,
recent studies have raised controversy on the interpretation of the
T1-w/T2-w ratio, showing that this measure may also reflect tissue
microstructure other than myelin, such as axon and dendrite density or
iron content (Arshad, Stanley, & Raz, 2017; Righart et al., 2017; Uddin,
Figley, Marrie, & Figley, 2018; van Rooden et al., 2014). Because
disrupted brain connectivity is an important feature of AD (Dicks et al.,
2018; Fornito et al., 2015; Pievani et al., 2014), an intracortical reduction
of myelin content in AD could be hypothesized. But also other pathologi-
cal factors associated with AD might lead to intracortical tissue changes.
To better understand what this myelin proxy in AD reflects, we com-
pared T1-w/T2-w ratio values between older adults with normal cogni-
tion and patients with AD-type dementia for the whole brain and on a
regional level. We further investigated the influence of factors that are
associated with AD, including cerebrospinal fluid (CSF) total-tau protein
concentration, white matter hyperintensities (WMH), and global cogni-
tive functioning that may contribute to alterations in T1-w/T2-w values.
2 | METHODS
2.1 | Participants
Individuals with normal cognition (NC) and with AD dementia who had
T1-weighted and T2-weighted structural MRI were selected from the
Amsterdam Dementia Cohort (Van Der Flier et al., 2014; Van Der Flier &
Scheltens, 2018). Probable AD dementia was diagnosed according to
NIA-AA criteria with evidence of abnormal levels of Aβ protein
(McKhann et al., 2011). Individuals with NC were required to have nor-
mal CSF Aβ1-42 levels. Participants were excluded if younger than
40 years old or if the MRI was acquired more than 3 months after clinical
diagnosis. All data was collected as part of routine dementia screening.
2.2 | CSF biomarkers
Collection of CSF by lumbar puncture for all subjects was performed
as described previously (Van Der Flier et al., 2014). Aβ1–42, phosphor-
ylated tau (p-tau), and total tau protein concentrations were measured
using InnoTest sandwich ELISAs (Innogenetics, Fujirebio, Ghent, Bel-
gium). The cut-off for abnormal drift-corrected CSF Aβ1–42 was set at
<813 ng/L (Tijms et al., 2018), at >375 ng/L for CSF total tau and at
>52 ng/L for p-tau (Mulder et al., 2010).
2.3 | MRI acquisition
Structural T1-weighted and T2-weighted images were acquired as part
of routine patient care from a single scanner (3T GE MR750). The follow-
ing parameters for T1 were used: 3D-FSPGR, sagittal plane, TR 7.8 ms, TE
3 ms, FA 12, voxel size 1 mm3, 5.06 min; for T2: 2D-TSE, axial plane, TR
8340 ms, TE 20.7 ms, FA 90, voxel size 0.5 × 0.5 × 3 mm3, 3.35 min.
To determine WMH, we additionally analyzed 3D-fluid attenuation
inversion recovery (FLAIR) images, acquired in a sagittal plane, with TR
8,000 ms, TE 126.6 ms, FA 90, voxel size 1 mm3, 5.48 min.
2.4 | MRI processing
T1-w and T2-w images were converted to Nifti format and analyzed
using a similar method as proposed by Glasser and Van Essen (2011). The
origin was manually set to the anterior commissure. The T2-weighted
image was rigidly registered with a 4th degree B-Spline interpolation to
the T1-weighted image using Statistical Parametric Mapping Software
version 12 (SPM12; Functional Imaging Laboratory, University College
London, London, UK) running in MATLAB 7.12 (MathWorks, Natick,
MA). The SPM12 segmentation function allowed for bias field correction
of both images, as well as tissue segmentation of the T1-w images into
CSF, GM, and WM tissue probability maps. For validation purposes, we
conducted analyses without field bias correction for the T1-w and T2-w
images as well, obtaining similar results but with less discriminative power
to detect differences in intracortical microstructure (Table S2). The data
presented here refer to the T1-w/T2-w images with bias correction. For
each subject, 90 cortical areas were identified with the automated ana-
tomical labeling (AAL) atlas (Tzourio-Mazoyer et al., 2002), using the SPM
normalize function with inverted deformation fields to warp the AAL atlas
to Montreal Neurological Institute (MNI) space. Interpolation was set to
nearest neighbor. The atlases were masked using subject-specific masks
covering voxels with a GM probability >.3. The T1-weighted image was
then divided by the T2-weighted image and masked with the GM mask
to obtain T1-w/T2-w ratios within 90 regions of the AAL atlas (Figure 1).
On the FLAIR sequence, WMH were assessed using the Fazekas scale
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(Fazekas, Chawluk, & Alavi, 1987) (0 = none; 1 = punctuate; 2 = early con-
fluent; and 3 = confluent) and dichotomized into absent (0–1) or present
(2–3). All images were visually inspected for segmentation or warping
errors; none had to be excluded.
2.5 | Statistical analysis
Demographic and biomarker data of the diagnostic groups were com-
pared using two-sample t tests for continuous data or chi-square tests
for categorical data. We used general linear models (GLM) to test
whether AD patients had globally (i.e., whole cortex) significantly dif-
ferent T1-w/T2-w ratios compared to the NC group. This analysis was
adjusted for sex and age as the T1-w/T2-w ratio has previously
shown to vary as a function of age. This model was repeated for
regional T1-w/T2-w values using Bonferroni correction for multiple
comparisons (i.e., p value of <.0005 for 90 AAL regions, 0.05/90), and
for analysis of individual T1-w and T2-w images as well.
To gain further insight into the biological underpinnings of the
T1-w/T2-w ratio, we further studied the influence of factors
known to be associated with AD, that is, WMH, tau, and Mini Men-
tal State Examination (MMSE), on T1-w/T2-w values. We used
GLM, adjusted for age and sex, to investigate whether WMH sever-
ity has an effect on the T1-w/T2-w ratio by comparing T1-w/T2-w
ratio values between individuals with WMH, defined as having a
Fazekas score 2–3, to individuals without pronounced WMH
(Fazekas 0–1).
Next, we computed a linear regression analysis of CSF total tau
concentration and mean T1-w/T2-w ratio values for all AAL regions
using all subjects and for each group separately. Previous studies have
shown that total tau and p-tau concentrations are highly correlated
(Mulder et al., 2010), therefore we chose to analyze the relationship
of T1-w/T2-w ratios with total-tau protein only, rather than also
p-tau. Furthermore, the correlation of the whole cortex and regional
T1-w/T2-w ratio and global cognitive performance score, as measured
by the MMSE was calculated. All statistical analyses were performed
in R (version 3.5.1), and brain images were visualized with Surf Ice
(version 10.14).
3 | RESULTS
3.1 | Demographic and clinical data
We included 293 AD and 172 NC subjects. AD patients had higher
tau levels than controls, were on average older, more likely to be
female, and showed more vascular brain damage, lower total GM vol-
ume and total WM volume compared to NC participants (Table 1).
The average anatomical distribution of T1-w/T2-w values across the
cortex in NC participants was qualitatively similar to myelin maps pre-
viously reported (Glasser & Van Essen, 2011) (Figure S1). Consistent
with their results we observed high T1-w/T2-w values in sensory
motor regions and visual cortex. The lowest T1-w/T2-w values are
located in the temporal (pole), anterior cingulate cortex, and frontal
areas corresponding with their findings as well.
3.2 | Altered intracortical T1-w/T2-w ratios in AD
Average whole cortex T1-w/T2-w values were higher in AD com-
pared to NC [NC: EMM = 1.004, SE = 0.009; AD: EMM = 1.038,
SE = 0.007; F(1, 464) = 8.33, d = 0.15, p < .01] (Estimated marginal
means (EMM); Figure 2). At regional level stronger effects were found,
with multiple brain regions showing higher T1-w/T2-w values in AD
(Figure 3). The largest differences were observed in the anterior
F IGURE 1 Flow diagram of preprocessing steps to generate
T1-w/T2-w images. Workflow of T1-w/T2-w image data processing
using SPM12, including registration of the T2-w image to the T1w-w
image, bias correction of both images, segmentation, warping of the
standard AAL atlas to a subject specific atlas. Finally, the T1-w/T2-w
image is calculated as the ratio of T1-w and T2-w images and masked
with a GM mask. AAL, automated anatomical labeling
TABLE 1 Demographic and clinical characteristics according to
diagnostic group
NC AD Total
(n = 172) (n = 293) (n = 465)
Sex, F 69 (40%) 159 (54%)* 228 (49%)
Age 59.0 ± 7.3 66.0 ± 7.7* 63.4 ± 8.3
MMSE score 28.3 ± 1.7 20.2 ± 5.0* 23.2 ± 5.7
CSF Aβ1-42 1138.7 ± 178.9 620.9 ± 98.0* 812.5 ± 283.7
CSF t-tau 229.1 ± 88.4 713.8 ± 466.9* 534.5 ± 441.6
CSF p-tau 42.8 ± 15.0 90.1 ± 43.1* 72.6 ± 42.2
Vascular damage 11 (6%) 71 (24%)* 82 (18%)
Gray matter volume 659.8 ± 66.9 552.4 ± 63.1* 592.2 ± 82.8
White matter volume 452.3 ± 52.0 415.9 ± 58.2* 429.4 ± 58.6
Cerebrospinal fluid 369.0 ± 78.7 486.3 ± 88.0* 443.0 ± 101.9
Notes: Data are presented as mean ± SD, or n (%). NC, normal cognition;
AD, Alzheimer's disease; F, female; age in years; MMSE, Mini Mental State
Examination (0–30); CSF, cerebrospinal fluid, CSF in ng/L; vascular
damage defined as Fazekas ≥2; volume in mm3; (*p < .05).
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cingulate, inferior parietal lobule, supramarginal gyrus, angular gyrus,
precuneus, and superior temporal gyrus (range d = 0.21 to d = 0.48;
p < .0005 to p < .00000001; Table S1). No regions with significantly
lower values were observed in AD.
Comparisons of individual images between diagnostic groups
resulted in no significant differences in T1-w image intensity. How-
ever uncorrected results showed a trend of higher T1-w image inten-
sity in AD patients in the inferior parietal lobule, angular gyrus,
precuneus, and superior parietal lobule. T2-w images showed signifi-
cantly lower intensities in the anterior cingulate in the AD group com-
pared to NC (p < .0005; Figure 4). And a trend toward lower T2-w
image intensity in AD patients in the inferior parietal lobule,
precuneus, hippocampus, and insula. Moreover, to exclude possible
age or sex effects, the main analysis was rerun using a subset (n = 50)
of age- and sex-matched individuals. Obtaining similar results, albeit
less significant (Table S3).
3.3 | Association of T1-w/T2-w ratio values with
other AD markers
There was no significant difference between the group with WMH
and the group without WMH in T1-w/T2-w values, regional or whole
brain [F(1, 463) = 0.92, p = .34, d = 0.004]. Next, the effect of the neu-
ronal injury marker tau on the mean global T1-w/T2-w ratio was
explored. The regression analysis indicated that T1-w/T2-w ratios
across the whole cortex increased with higher tau concentrations in
CSF (r = .11, p < .01; Figure 5a). These associations were specific for
the AD group (AD: r = .12, p < .05; CN: r = −.07, p = .40) and located
in mostly frontal and parietal regions with significant correlation
values ranging from r = .16 to .22 (all p < .0005; Figure 5b), and
remained when adjusting for age and sex. Note that we did not inves-
tigate the relationship of CSF Aβ levels and T1-w/T2-w ratio as the
diagnostic groups already reflect this association, because CN and AD
subjects were selected based on their amyloid status. We further ana-
lyzed the mean whole cortex correlation between T1-w/T2-w ratio
and MMSE scores which was r = −.08, with p-value = .08 (AD:
r = −.05, p = .34; CN: r = .08, p = .34). Which implies that worse global
cognitive functioning correlated with higher T1-w/T2-w ratios at a
trend level (Figure 5c), and regionally stronger associations were
observed, which remained when adjusting for age and sex, mostly in
temporal, cingulate, and parietal brain areas (range r = −.16 to
r = −.21, all p < .0005; Figure 5d).
4 | DISCUSSION
The main finding of our study was that T1-w/T2-w ratio values were
higher in AD compared to controls, which was contrary to our expec-
tation. These changes tended to be most pronounced in anatomical
areas known to be affected in AD such as the interior parietal lobule
and precuneus, and were associated with higher levels of the neuronal
injury marker tau and worse cognition.
F IGURE 2 Violin plot representation of mean T1-w/T2-w ratio
values in all GM regions for AD and NC. Global, that is, whole brain,
average T1-w/T2-w ratios are significantly higher in AD compared to CN
subjects, adjusted for age, and sex. NC (n = 172): EMM = 1.004,
SE = 0.009; AD (n = 293): EMM = 1.038, SE = 0.007; F(1, 464) = 8.326,
d = 0.15, p < .005. Note: plot created with raw data (without covariates).
AD, Alzheimer's disease; EMM, estimated marginal means; NC, normal
cognition
F IGURE 3 p-value map of AAL regions with significant different
T1-w/T2-w ratios between AD and NC subjects. Higher T1-w/T2-w
ratio values were found widespread in AD, in particular in AD-related
regions: superior and middle frontal gyrus; inferior frontal gyrus pars
opercularis and triangularis; rolandic operculum; insula; anterior, mid
and posterior cingulate gyrus; calcarine; cuneus; middle occipital
gyrus; superior and inferior parietal lobule; supramarginal gyrus;
angular gyrus; precuneus; superior and middle temporal gyrus. All
analyses were adjusted for multiple comparisons showing a moderate
(Yellow p < .0005) to highly (Red p < .000000001) significance scale.
AAL, automated anatomical labeling; AD, Alzheimer's disease; NC,
normal cognition [Color figure can be viewed at
wileyonlinelibrary.com]
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Previous studies have suggested that myelin is the predominant
source of MR contrast in T1-weighted and T2-weighted images (Bock,
Kocharyan, Liu, & Silva, 2009; Eickhoff et al., 2005; Laule et al., 2007;
Wallace et al., 2016), and by using the ratio of these images the con-
trast sensitivity to detect myelin content is increased further due to
attenuation of the shared intensity biases (Glasser & Van Essen,
2011). Although, other studies have questioned the sensitivity of the
T1-w/T2-w ratio for myelin content, and argued that it is likely not
the only factor contributing to the T1-w/T2-w image (Arshad et al.,
2017; Righart et al., 2017; Uddin et al., 2018). Still, it has been shown
that T1-w/T2-w ratio differentiates between high and low myelinated
cortex as determined by myelin proteolipid protein staining
(Nakamura et al., 2017). Also in our study, we observed no indication
that our T1-w/T2-w map differed from those previously reported in
NC, with high T1-w/T2-w values in regions such as the basal ganglia,
thalamus, and paracentral lobule (Ganzetti, Wenderoth, & Mantini,
2015) and low T1-w/T2-w ratios in the insula, anterior cingulate, hip-
pocampus, medial orbitofrontal gyrus, and temporal pole (Fischl et al.,
2004; Glasser, Goyal, Preuss, Raichle, & Van Essen, 2014), suggesting
it correlates well with cortical myelination.
To the best of our knowledge, this technique has not been applied
in AD dementia before, however, a previous study showed that higher
T1-w/T2-w values correlated with amyloid beta deposition on
positron-emission tomography (PET) in individuals with normal cogni-
tion (Yasuno et al., 2017). Our observation of higher T1-w/T2-w
seems in line with that study. The authors found higher regional
T1-w/T2-w ratios in the frontal cortex and anterior cingulate in sub-
jects with high PiB binding compared to subjects with low PiB binding
and suggested that microstructural alterations induced by amyloid
beta could be detected with the T1-w/T2-w ratio. In our study, the
higher T1-w/T2-w ratio in AD also seem to be regionally specific,
showing the highest T1-w/T2-w ratios in AD patients in the angular
gyrus, inferior parietal lobule, precuneus, anterior cingulate,
supramarginal gyrus, and superior temporal gyrus. These high
T1-w/T2-w regions overlap with areas known be involved in AD, and
have been associated with the “default mode network,” a set of brain
areas that shows high functional correlations when a person is not
performing a task. In particular, these regions seem most vulnerable
for early amyloid depositions and decreased functional connectivity in
AD (Buckner, 2005; Palmqvist et al., 2017). Additionally, this corre-
sponds with numerous studies showing that particularly late-
myelinating, that is temporal and frontal, intracortical fibers seem par-
ticularly prone to lose myelin (Bartzokis et al., 2004; Brettschneider,
Del Tredici, Lee, & Trojanowski, 2015; Jucker & Walker, 2018; Thal,
Rüb, Orantes, & Braak, 2002). The sensory and motor regions, that is
early myelinating, showed little difference in T1-w/T2-w ratio
between AD and NC individuals. These regions are known to have a
relative sparing of AD pathology until late disease stages (Bartzokis,
Lu, & Mintz, 2007). Although the relationships were not strong, our
findings showed an association of higher T1-w/T2-w ratios in mostly
frontal and parietal areas with increased tau pathology, and higher
T1-w/T2-w ratios in mainly temporal areas with a decline in global
cognitive functioning, suggesting that the cortical changes detected
by the T1-w/T2-w ratio show a regional vulnerability and an associa-
tion with pathology.
Additionally, we analyzed the intensity measures derived from the
T1-w and T2-w images separately. GM T1-w images did not show sig-
nificant differences in intensity between NC and AD groups. How-
ever, T2-w images had significantly lower intensities in the anterior
cingulate and inferior parietal lobule in the AD group compared to
NC. Therefore, the group difference in T1-w/T2-w ratios seems to be
predominantly driven by the overall lower T2-w signal in AD patients.
A finding that might be related to increased Aβ protein concentra-
tions, which are known to decrease the T2-w signal (Imon et al.,
1995). When applying the ratio of T1-w by T2-w images, it greatly
F IGURE 4 p-value map of AAL regions with different T1-w images, T2-w images, and 1/T2-w images between AD and NC subjects.
Figures shown are uncorrected for multiple comparisons to give insight into the pattern of regions that differed between groups at a trend level.
(a) Surfaceplot shows a trend of higher T1-w image intensity in AD patients in the inferior parietal lobule, angular gyrus, precuneus, and superior
parietal lobule. (b) T2-w images had significantly lower intensities in the anterior cingulate in the AD group. And showed a trend toward lower
T2-w image intensity in AD patients in the inferior parietal lobule, precuneus, hippocampus, and insula. (c) Surfaceplot shows a trend of higher
1/T2-w image intensity in AD patients in the anterior cingulate gyrus, inferior parietal lobule, hippocampus, and precuneus. Displayed are regions
with a p-value scale of (yellow p < .01) to (red p < .0001). AAL, automated anatomical labeling; AD, Alzheimer's disease; NC, normal cognition
[Color figure can be viewed at wileyonlinelibrary.com]
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improves the sensitivity to detect subtle differences, than using single
modalities separately.
However, it remains unclear what biological substrate higher
T1-w/T2-w values reflect. Disorders with a strong demyelinating
component such as MS, have consistently showed lower T1-w/T2-w
values in pathologically vulnerable regions (Beer et al., 2016;
Nakamura et al., 2017; Righart et al., 2017). Additionally, lowered
T1-w/T2-w ratios in several brain regions in schizophrenia (Ganzetti
et al., 2015; Iwatani et al., 2015) and bipolar disorder patients (Ishida
et al., 2017) have been identified. Recent transcriptomic studies have
further observed correlations of the T1-w/T2-w intensity in the cor-
tex with expression of genes associated with cortical microcircuit spe-
cialization and myelin (Burt et al., 2018; Ritchie, Pantazatos, & French,
2018). In contrast, recently a study with Parkinson disease patients
showed a higher T1-w/T2-w ratio in the substantia nigra pars com-
pacta compared to controls (Du, Lewis, Sica, Kong, & Huang, 2018).
Also in Huntington disease, higher T1-w/T2-w ratios in several corti-
cal regions including the insula, ventrolateral frontal cortex, and
medial temporal pole were found (Rowley et al., 2018). This
incongruency suggests that in AD either demyelination does not
F IGURE 5 Association of T1-w/T2-w ratio values with other AD markers. (a) Global T1-w/T2-w ratio as a function of tau. Scatterplot
showing an association of higher T1-w/T2-w ratios with abnormal CSF tau concentrations in the total sample. Regression line in black, the
95% CI in shaded gray. (b) Surfacemap showing regional associations of CSF total tau concentration with T1-w/T2-w values. Higher tau
concentrations are associated with higher T1-w/T2-w ratios in the superior and middle frontal gyrus, pars triangularis, medial frontal gyrus,
superior occipital, postcentral gyrus, superior and inferior parietal lobule, supramarginal gyrus, angular gyrus, precuneus, and superior temporal
gyrus across all subjects (range r = .15 to r = .22; p = .0005 to p = .000001). (c) Global T1-w/T2-w ratio as a function of MMSE score. Scatterplot
showing the relation between global T1-w/T2-w ratios according to MMSE score in the total sample. Regression line in black, the 95% CI in
shaded gray. (d) Surfacemap showing regional associations of MMSE scores with T1-w/T2-w values. Lower MMSE scores are associated with
higher T1-w/T2-w ratios in the middle frontal gyrus, insula, anterior cingulate gyrus, inferior parietal lobule, supramarginal gyrus, angular gyrus,
precuneus, superior and middle temporal gyrus across all subjects (range r = .15 to r = .21; p = .0005 to p = .000008). AD, Alzheimer's disease;
CSF, cerebrospinal fluid; MMSE, Mini Mental State Examination [Color figure can be viewed at wileyonlinelibrary.com]
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occur, or the T1-w/T2-w ratio measures something different rather
than myelin content. Still, structural imaging and histological studies
have reported a disruption in WM integrity in AD (Bartzokis et al.,
2004; Carmichael et al., 2010; Filley & Fields, 2016; Nir et al., 2013;
Rowley et al., 2013). For example, more white matter hyperintensities
have been related to an increased risk of dementia and cognitive defi-
cits, independently of vascular risk factors and stroke in the AD con-
tinuum (Debette et al., 2010; Gordon et al., 2015; Nir et al., 2013).
Cortical demyelination in the context of AD has been demonstrated
also in the medial temporal lobe and lingual gyri using the magnetiza-
tion transfer ratio in mild cognitive impairment patients (Carmeli et al.,
2013). Moreover, focal demyelination of the cortical gray matter has
been reported around Aβ plaques, suggesting a vulnerability of
myelin to Aβ toxicity (Mitew et al., 2010). Therefore, we consider it
unlikely that no demyelination occurs in AD. Another possibility is
remyelination (Peters, 2009), which has also been suggested by a
recent study by Bulk et al. (2018). Using a combined post mortem
T2*wMRI with histology, the authors showed an unexpected increase
in cortical myelin staining in late stage AD (Bulk et al., 2018). The
increase in myelin density did show a more disorganized cortical mye-
lin architecture compared to controls. Furthermore, Van Duijn et al.
(2017) also found increased myelin protein labeling in regions affected
severely by Aβ and tau pathology. Possibly, adequate intracortical
myelin plasticity may initially compensate for the subcortical transmis-
sion delays along WM subcortical fibers, but eventually during the dis-
ease course significant intracortical oligodendrocyte deficits develop.
Note however, that Bulk et al. (2018), and multiple other studies
(Ayton et al., 2019; Connor, Snyder, Beard, Fine, & Mufson, 1992;
Ward, Zucca, Duyn, Crichton, & Zecca, 2014; Zecca, Youdim,
Riederer, Connor, & Crichton, 2004), also demonstrated increased iron
accumulation in AD. T2-w sequences are known to be highly sensitive
to iron deposits, and so the T1-w/T2-w ratio may reflect the presence
of both processes (Dusek, Dezortova, & Wuerfel, 2013). Because
there is a strong colocalization of myelin and iron in the cortex
(Fukunaga et al., 2010; Quintana et al., 2006; Stüber et al., 2014), this
would imply that even though iron may contribute to the T1-w/T2-w
signal, the T1-w/T2-w signal would still mainly (directly and indirectly)
reflect the underlying myeloarchitecture. However in pathological
conditions such as AD, the relationship of myelin and iron may be
altered, for instance by loss of oligodendrocytes or iron rich depositions
around Aβ plaques (Hare, Ayton, Bush, & Lei, 2013). There is also evi-
dence that brain regions originally low in iron content, such as the fron-
tal and temporal lobe, appear to be most vulnerable to iron
dyshomeostasis and are susceptible to amyloid pathology (Connor
et al., 1992; Hallgren & Sourander, 1958). In other words, there appears
to be a synergy of iron and β-amyloid toxicity in specific brain regions
that overlap with regions we observed to show high T1-w/T2-w ratios
in AD. Future research should further investigate this question using a
combined PET and MR approach. To summarize, the T1-w/T2-w ratio
is likely to be influenced by other microstructural factors than myelin
and does not seem suited as a measure for disrupted cortical mye-
lination in diseased cohorts. Rather, more studies are needed to
measure these other pathological processes at the same time in AD to
further understand what T1-w/T2-w changes in AD reflect.
There are some limitations to our study. As data was collected in
clinical setting, our analysis were not identical to the original approach
of Glasser and Van Essen (2011), including different acquisition
parameters, that is, isotropic voxels for both images versus non-
isotropic voxels for T2-w images in our study. As a consequence, our
analyses may be more prone to partial volume effects. To study possi-
ble contamination from non-GM tissue classes, we repeated analyses
in a subset of individuals including only voxels with increasing GM
probabilities and the use of an eroded GM mask. Findings were con-
sistent to the main analyses, suggesting that our results cannot simply
be explained by differences in partial volume effects (Figures S2
and S3). Furthermore, as we used a volumetric approach, we are
unable to exclude the possibility that cortical layering patterns may
have influenced the T1-w/T2-w ratio. Future studies should compare
volumetric approaches with for example, a surface-based registration
that might better account for each person's cortical folding pattern
(Fischl, Sereno, & Dale, 1999). Moreover, the differences in
T1-w/T2-w ratio between AD and NC individuals are highly signifi-
cant, however the effect sizes are too small to be of clinical signifi-
cance. Another limitation is that we have no pathological data
available to further study whether T1-w/T2-w corresponds to myelin
in the same individuals: future research should take confounding
effects such as iron and inflammation into account and histologically
quantify the T1-w/T2-w in healthy and pathological tissue. Alongside
this, the large sample size, the use of the same scanning protocol for
all subjects, and the use of AD biomarkers strengthens our study.
In conclusion, our findings of higher T1-w/T2-w values in AD sug-
gest that this measure may not (only) reflect myelin content. Currently
the T1-w/T2-w ratio is used frequently across various populations to
characterize myelin. Our results suggest that this measure should be
interpreted with caution in particular in disease populations and fur-
ther validation and characterization of the T1-w/T2-w ratio and its
neurobiological origin in AD is necessary for correct interpretation.
ACKNOWLEDGMENTS
Research of the VUmc Alzheimer Center is part of the neu-
rodegeneration research program of Amsterdam Neuroscience (www.
amsterdamresearch.org). The Alzheimer Center Amsterdam is
supported by Stichting Alzheimer Nederland and Stichting VUmc
fonds. The clinical database structure was developed with funding
from Stichting Dioraphte. I wish to thank Dr. Steenwijk for his valu-
able advice on this project.
DISCLOSURES
W. Pelkmans and E. Dicks report no disclosures. F. Barkhof is a consultant
for Biogen-Idec, Janssen Alzheimer Immunotherapy, Bayer-Schering,
Merck-Serono, Roche, Novartis, Genzume, and Sanofi-Aventis; has
received sponsoring fromEuropeanCommission–Horizon 2020, National
Institute for Health Research–University College London Hospitals
PELKMANS ET AL. 7
Biomedical Research Centre, Scottish Multiple Sclerosis Register, TEVA,
Novartis, and Toshiba; is supported by the University College London
Hospitals NHS Foundation Trust Biomedical Research Center; and serves
on the editorial boards of Radiology, Brain, Neuroradiology,Multiple Scle-
rosis Journal, and Neurology. H. Vrenken reports no disclosures.
P. Scheltens has acquired grant support (for the institution) from
BiogenGE Healthcare, Danone Research, Piramal, and Merck. In the past
2 years, he has received consultancy/speaker fees (paid to the institution)
from Lilly, GE Healthcare, Novartis, Sanofi, Nutricia, Probiodrug, Biogen,
Roche, Avraham, and EIP Pharma, Merck AG. W. M. van der Flier's
research programs have been funded by ZonMW, the Netherlands Orga-
nization of Scientific Research, Seventh European Framework Pro-
gramme, Alzheimer Nederland, Cardiovascular Onderzoek Nederland,
Stichting Dioraphte, Gieskes-Strijbis fonds, Boehringer Ingelheim, Piramal
Imaging, Roche BV, Janssen Stellar, Biogen MA and Combinostics. All
funding is paid to her institution. B. M. Tijms declares that she is
supported by the ZonMWMemorabel “(Grant number #73305056).”
ORCID
Wiesje Pelkmans https://orcid.org/0000-0002-6708-5374
REFERENCES
Arshad, M., Stanley, J. A., & Raz, N. (2017). Test–retest reliability and con-
current validity of in vivo myelin content indices: Myelin water frac-
tion and calibrated T1w/T2w image ratio. Human Brain Mapping, 38(4),
1780–1790. https://doi.org/10.1002/hbm.23481
Ayton, S., Wang, Y., Diouf, I., Schneider, J. A., Brockman, J., Morris, M. C., &
Bush, A. I. (2019). Brain iron is associated with accelerated cognitive
decline in people with Alzheimer pathology. Molecular Psychiatry.
https://doi.org/10.1038/s41380-019-0375-7
Bartzokis, G., Lu, P. H., & Mintz, J. (2007). Human brain myelination and
amyloid beta deposition in Alzheimer's disease. Alzheimers Dement, 3
(2), 122–125.
Bartzokis, G., Sultzer, D., Lu, P. H., Nuechterlein, K. H., Mintz, J., &
Cummings, J. L. (2004). Heterogeneous age-related breakdown of
white matter structural integrity: Implications for cortical “disconnec-
tion” in aging and Alzheimer's disease. Neurobiology of Aging, 25(7),
843–851. https://doi.org/10.1016/j.neurobiolaging.2003.09.005
Beer, A., Biberacher, V., Schmidt, P., Righart, R., Buck, D., Berthele, A., …
Mühlau, M. (2016). Tissue damage within normal appearing white mat-
ter in early multiple sclerosis: Assessment by the ratio of T1- and
T2-weighted MR image intensity. Journal of Neurology, 263(8),
1495–1502. https://doi.org/10.1007/s00415-016-8156-6
Bock, N. A., Kocharyan, A., Liu, J. V., & Silva, A. C. (2009). Visualizing the
entire cortical myelination pattern in marmosets with magnetic reso-
nance imaging. Journal of Neuroscience Methods, 185(1), 15–22.
https://doi.org/10.1016/j.jneumeth.2009.08.022
Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-
related changes. Acta Neuropathologica, 82(4), 239–259. https://doi.
org/10.1007/BF00308809
Brettschneider, J., Del Tredici, K., Lee, V. M. Y., & Trojanowski, J. Q.
(2015). Spreading of pathology in neurodegenerative diseases: A focus
on human studies. Nature Reviews Neuroscience, 16(2), 109–120.
https://doi.org/10.1038/nrn3887
Buckner, R. L. (2005). Molecular, structural, and functional characterization
of Alzheimer's disease: Evidence for a relationship between default
activity, amyloid, and memory. Journal of Neuroscience, 25(34),
7709–7717. https://doi.org/10.1523/JNEUROSCI.2177-05.2005
Bulk, M., Abdelmoula, W. M., Nabuurs, R. J. A., van der Graaf, L. M.,
Mulders, C. W. H., Mulder, A. A., … van der Weerd, L. (2018). Postmor-
tem MRI and histology demonstrate differential iron accumulation and
cortical myelin organization in early- and late-onset Alzheimer's dis-
ease. Neurobiology of Aging, 62, 231–242. https://doi.org/10.1016/j.
neurobiolaging.2017.10.017
Burt, J. B., Demirtas¸ , M., Eckner, W. J., Navejar, N. M., Ji, J. L.,
Martin, W. J., … Murray, J. D. (2018). Hierarchy of transcriptomic spe-
cialization across human cortex captured by structural neuroimaging
topography. Nature Neuroscience, 21(9), 1251–1259. https://doi.org/
10.1038/s41593-018-0195-0
Carmeli, C., Donati, A., Antille, V., Viceic, D., Ghika, J., von Gunten, A., …
Knyazeva, M. G. (2013). Demyelination in mild cognitive impairment
suggests progression path to Alzheimer's disease. PLoS One, 8(8),
e72759. https://doi.org/10.1371/journal.pone.0072759
Carmichael, O., Schwarz, C., Drucker, D., Fletcher, E., Harvey, D.,
Beckett, L., … DeCarli, C. (2010). Longitudinal changes in white matter
disease and cognition in the first year of the Alzheimer disease neuro-
imaging initiative. Archives of Neurology, 67(11), 1370–1378. https://
doi.org/10.1001/archneurol.2010.284
Chua, T. C., Wen, W., Slavin, M. J., & Sachdev, P. S. (2008). Diffusion ten-
sor imaging in mild cognitive impairment and Alzheimer's disease:
A review. Current Opinion in Neurology, 21(1), 83–92. https://doi.org/
10.1097/WCO.0b013e3282f4594b
Connor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J. (1992).
Regional distribution of iron and iron-regulatory proteins in the brain
in aging and Alzheimer's disease. Journal of Neuroscience Research, 31
(0360–4012), 327–335.
de Rochefort, L., Brown, R., Prince, M. R., & Wang, Y. (2008). Quantitative
MR susceptibility mapping using piece-wise constant regularized
inversion of the magnetic field. Magnetic Resonance in Medicine, 60(4),
1003–1009. https://doi.org/10.1002/mrm.21710
Debette, S., Beiser, A., Decarli, C., Au, R., Himali, J. J., Kelly-Hayes, M., …
Seshadri, S. (2010). Association of MRI markers of vascular brain injury
with incident stroke, mild cognitive impairment, dementia, and mortal-
ity: The Framingham offspring study. Stroke, 41(4), 600–606. https://
doi.org/10.1161/STROKEAHA.109.570044
Dicks, E., Tijms, B. M., ten Kate, M., Gouw, A. A., Benedictus, M. R.,
Teunissen, C. E., … van der Flier, W. M. (2018). Gray matter network
measures are associated with cognitive decline in mild cognitive
impairment. Neurobiology of Aging, 61, 198–206. https://doi.org/10.
1016/j.neurobiolaging.2017.09.029
Du, G., Lewis, M. M., Sica, C., Kong, L., & Huang, X. (2018). Magnetic reso-
nance T1w/T2w ratio: A parsimonious marker for Parkinson disease.
Annals of Neurology, 85, 1–9. https://doi.org/10.1002/ana.25376
Dusek, P., Dezortova, M., & Wuerfel, J. (2013). Imaging of iron. In Interna-
tional review of neurobiology. In K. P. Bhatia, & S. A. Schneider (Eds.),
(Vol. 110, 1st ed., pp. 195–239). Elsevier Inc.
Eickhoff, S., Walters, N. B., Schleicher, A., Kril, J., Egan, G. F., Zilles, K., …
Amunts, K. (2005). High-resolution MRI reflects myeloarchitecture
and cytoarchitecture of human cerebral cortex. Human Brain Mapping,
24(3), 206–215. https://doi.org/10.1002/hbm.20082
Fazekas, F., Chawluk, J. B., & Alavi, A. (1987). MR signal abnormalities at
1.5 T in Alzheimer's dementia and normal aging. American Journal of
Neuroradiology, 8(3), 421–426. https://doi.org/10.2214/ajr.149.2.351
Filley, C. M., & Fields, R. D. (2016). White matter and cognition: Making
the connection. Journal of Neurophysiology, 116(5), 2093–2104.
https://doi.org/10.1152/jn.00221.2016
Fischl, B., Salat, D. H., Van Der Kouwe, A. J. W., Makris, N., Ségonne, F.,
Quinn, B. T., & Dale, A. M. (2004). Sequence-independent segmenta-
tion of magnetic resonance images. NeuroImage, 23(Suppl. 1),
S69–S84. https://doi.org/10.1016/j.neuroimage.2004.07.016
8 PELKMANS ET AL.
Fischl, B., Sereno, M. I., & Dale, A. M. (1999). Cortical surface-based analy-
sis. II: Inflation, flattening, and a surface-based coordinate system.
NeuroImage, 207(9), 195–207.
Fornito, A., Zalesky, A., & Breakspear, M. (2015). The connectomics of
brain disorders. Nature Reviews Neuroscience, 16(3), 159–172. https://
doi.org/10.1038/nrn3901
Fukunaga, M., Li, T.-Q., van Gelderen, P., de Zwart, J. A., Shmueli, K.,
Yao, B., … Duyn, J. H. (2010). Layer-specific variation of iron content
in cerebral cortex as a source of MRI contrast. Proceedings of the
National Academy of Sciences of the United States of America, 107(8),
3834–3839. https://doi.org/10.1073/pnas.0911177107
Ganzetti, M., Wenderoth, N., & Mantini, D. (2015). Mapping pathological
changes in brain structure by combining T1- and T2-weighted MR
imaging data. Neuroradiology, 57(9), 917–928. https://doi.org/10.
1007/s00234-015-1550-4
Gao, J., Cheung, R. T. F., Chan, Y. S., Chu, L. W., Mak, H. K. F., &
Lee, T. M. C. (2014). The relevance of short-range fibers to cognitive
efficiency and brain activation in aging and dementia. PLoS One, 9(4),
e90307. https://doi.org/10.1371/journal.pone.0090307
Glasser, M. F., Goyal, M. S., Preuss, T. M., Raichle, M. E., & Van
Essen, D. C. (2014). Trends and properties of human cerebral cortex:
Correlations with cortical myelin content. NeuroImage, 93, 165–175.
https://doi.org/10.1016/j.neuroimage.2013.03.060
Glasser, M. F., & Van Essen, D. C. (2011). Mapping human cortical areas
in vivo based on myelin content as revealed by T1- and T2-weighted
MRI. Journal of Neuroscience, 31(32), 11597–11616. https://doi.org/
10.1523/JNEUROSCI.2180-11.2011
Gordon, B. A., Najmi, S., Hsu, P., Roe, C. M., Morris, J. C., & Benzinger, T. L. S.
(2015). The effects of white matter hyperintensities and amyloid deposi-
tion on Alzheimer dementia. NeuroImage: Clinical, 8, 246–252. https://
doi.org/10.1016/j.nicl.2015.04.017
Grydeland, H., Vértes, P. E., Váša, F., Romero-Garcia, R., Whitaker, K.,
Alexander-Bloch, A. F., … Bullmore, E. T. (2019). Waves of maturation
and senescence in micro-structural MRI markers of human cortical
myelination over the lifespan. Cerebral Cortex, 29(3), 1369–1381.
https://doi.org/10.1093/cercor/bhy330
Grydeland, H., Walhovd, K. B., Tamnes, C. K., Westlye, L. T., & Fjell, A. M.
(2013). Intracortical myelin links with performance variability across
the human lifespan: Results from T1- and T2-weighted MRI myelin
mapping and diffusion tensor imaging. Journal of Neuroscience, 33(47),
18618–18630. https://doi.org/10.1523/jneurosci.2811-13.2013
Hallgren, B., & Sourander, P. (1958). The effect of age on the non-haemin
iron in the human brain. Journal of Neurochemistry, 3(1), 41–51.
https://doi.org/10.1111/j.1471-4159.1958.tb12607.x
Hare, D., Ayton, S., Bush, A., & Lei, P. (2013). A delicate balance: Iron
metabolism and diseases of the brain. Frontiers in Aging Neuroscience,
5, 1–19. https://doi.org/10.3389/fnagi.2013.00034
Heath, F., Hurley, S. A., Johansen-Berg, H., & Sampaio-Baptista, C. (2018).
Advances in noninvasive myelin imaging. Developmental Neurobiology,
78(2), 136–151. https://doi.org/10.1002/dneu.22552
Imon, Y., Yamaguchi, S., Yamamura, Y., Tsuji, S., Kajima, T., Ito, K., &
Nakamura, S. (1995). Low intensity areas observed on T2-weighted
magnetic resonance imaging of the cerebral cortex in various neuro-
logical diseases. Journal of the Neurological Sciences, 134(Suppl.),
27–32. https://doi.org/10.1016/0022-510X(95)00205-G
Ishida, T., Donishi, T., Iwatani, J., Yamada, S., Takahashi, S., Ukai, S., &
Kaneoke, Y. (2017). Elucidating the aberrant brain regions in bipolar
disorder using T1-weighted/T2-weighted magnetic resonance ratio
images. Psychiatry Research - Neuroimaging, 263, 76–84. https://doi.
org/10.1016/j.pscychresns.2017.03.006
Iwatani, J., Ishida, T., Donishi, T., Ukai, S., Shinosaki, K., Terada, M., &
Kaneoke, Y. (2015). Use of T1-weighted/T2-weighted magnetic reso-
nance ratio images to elucidate changes in the schizophrenic brain.
Brain and Behavior, 5(10), 1–14. https://doi.org/10.1002/brb3.399
Jucker, M., & Walker, L. C. (2018). Propagation and spread of pathogenic
protein assemblies in neurodegenerative diseases. Nature Neurosci-
ence, 21(10), 1341–1349. https://doi.org/10.1038/s41593-018-
0238-6
Laule, C., Vavasour, I. M., Kolind, S. H., Li, D. K. B., Traboulsee, T. L.,
Moore, G. R. W., & MacKay, A. L. (2007). Magnetic resonance imaging
of myelin. Neurotherapeutics: The Journal of the American Society for
Experimental NeuroTherapeutics, 4(3), 460–484. https://doi.org/10.
1016/j.nurt.2007.05.004
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R.,
Kawas, C. H., … Phelps, C. H. (2011). The diagnosis of dementia due to
Alzheimer's disease: Recommendations from the National Institute on
Aging-Alzheimer's Association workgroups on diagnostic guidelines
for Alzheimer's disease. Alzheimer's & Dementia, 7(3), 263–269.
https://doi.org/10.1016/j.jalz.2011.03.005
Mitew, S., Kirkcaldie, M. T. K., Halliday, G. M., Shepherd, C. E., Vickers, J. C., &
Dickson, T. C. (2010). Focal demyelination in Alzheimer's disease and
transgenic mouse models. Acta Neuropathologica, 119(5), 567–577.
https://doi.org/10.1007/s00401-010-0657-2
Mulder, C., Verwey, N. A., Van Der Flier, W. M., Bouwman, F. H., Kok, A.,
Van Elk, E. J., … Blankenstein, M. A. (2010). Amyloid-β(1-42), total tau,
and phosphorylated tau as cerebrospinal fluid biomarkers for the diag-
nosis of Alzheimer disease. Clinical Chemistry, 56(2), 248–253. https://
doi.org/10.1373/clinchem.2009.130518
Nakamura, K., Chen, J. T., Ontaneda, D., Fox, R. J., & Trapp, B. D. (2017).
T1−/T2-weighted ratio differs in demyelinated cortex in multiple scle-
rosis. Annals of Neurology, 82(4), 635–639. https://doi.org/10.1002/
ana.25019
Nave, K.-A., & Werner, H. B. (2014). Myelination of the nervous system:
Mechanisms and functions. Annual Review of Cell and Developmental
Biology, 30(1), 503–533. https://doi.org/10.1146/annurev-cellbio-
100913-013101
Nieuwenhuys, R., & Broere, C. A. J. (2017). A map of the human neocortex
showing the estimated overall myelin content of the individual archi-
tectonic areas based on the studies of Adolf Hopf. Brain Structure and
Function, 222(1), 465–480. https://doi.org/10.1007/s00429-016-
1228-7
Nir, T. M., Jahanshad, N., Villalon-Reina, J. E., Toga, A. W., Jack, C. R.,
Weiner, M. W., & Thompson, P. M. (2013). Effectiveness of regional
DTI measures in distinguishing Alzheimer's disease, MCI, and normal
aging. NeuroImage: Clinical, 3, 180–195. https://doi.org/10.1016/j.nicl.
2013.07.006
Palmqvist, S., Schöll, M., Strandberg, O., Mattsson, N., Stomrud, E.,
Zetterberg, H., … Hansson, O. (2017). Earliest accumulation of
β-amyloid occurs within the default-mode network and concurrently
affects brain connectivity. Nature Communications, 8(1), 1214. https://
doi.org/10.1038/s41467-017-01150-x
Peters, A. (2009). The effects of normal aging on myelinated nerve fibers
in monkey central nervous system. Frontiers in Neuroanatomy, 3, 1–10.
https://doi.org/10.3389/neuro.05.011.2009
Pievani, M., Filippini, N., Van Den Heuvel, M. P., Cappa, S. F., &
Frisoni, G. B. (2014). Brain connectivity in neurodegenerative diseases
- from phenotype to proteinopathy. Nature Reviews Neurology, 10(11),
620–633. https://doi.org/10.1038/nrneurol.2014.178
Quintana, C., Bellefqih, S., Laval, J. Y., Guerquin-Kern, J. L., Wu, T. D.,
Avila, J., … Patiño, C. (2006). Study of the localization of iron, ferritin,
and hemosiderin in Alzheimer's disease hippocampus by analytical
microscopy at the subcellular level. Journal of Structural Biology, 153(1),
42–54. https://doi.org/10.1016/j.jsb.2005.11.001
Righart, R., Biberacher, V., Jonkman, L. E., Klaver, R., Schmidt, P., Buck, D.,
… Mühlau, M. (2017). Cortical pathology in multiple sclerosis detected
by the T1/T2-weighted ratio from routine magnetic resonance imag-
ing. Annals of Neurology, 82(4), 519–529. https://doi.org/10.1002/ana.
25020
PELKMANS ET AL. 9
Ritchie, J., Pantazatos, S. P., & French, L. (2018). Transcriptomic characteri-
zation of MRI contrast with focus on the T1-w/T2-w ratio in the cere-
bral cortex. NeuroImage, 174, 504–517. https://doi.org/10.1016/j.
neuroimage.2018.03.027
Rowley, C. D., Tabrizi, S. J., Scahill, R. I., Leavitt, B. R., Roos, R. A. C., Durr, A., &
Bock, N. A. (2018). Altered intracortical T1-weighted/T2-weighted ratio
signal in Huntington's disease. Frontiers in Neuroscience, 12, 1–9. https://
doi.org/10.3389/fnins.2018.00805
Rowley, J., Fonov, V., Wu, O., Eskildsen, S. F., Schoemaker, D., Wu, L., …
Rosa-Neto, P. (2013). White matter abnormalities and structural hip-
pocampal disconnections in amnestic mild cognitive impairment and
Alzheimer's disease. PLoS One, 8(9), e74776. https://doi.org/10.1371/
journal.pone.0074776
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B.,
Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016). Alzheimer's
disease. The Lancet, 388(10043), 505–517. https://doi.org/10.1016/
S0140-6736(15)01124-1
Selkoe, D. J. (2002). Alzheimer's disease is a synaptic failure. Science, 298
(5594), 789–791. https://doi.org/10.1126/science.1074069
Shafee, R., Buckner, R. L., & Fischl, B. (2015). Gray matter myelination of
1555 human brains using partial volume corrected MRI images.
NeuroImage, 105, 473–485. https://doi.org/10.1016/j.neuroimage.
2014.10.054
Stüber, C., Morawski, M., Schäfer, A., Labadie, C., Wähnert, M., Leuze, C.,
… Turner, R. (2014). Myelin and iron concentration in the human brain:
A quantitative study of MRI contrast. NeuroImage, 93, 95–106.
https://doi.org/10.1016/j.neuroimage.2014.02.026
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002). Phases of Aβ-
deposition in the human brain and its relevance for the development
of AD. Neurology, 58(12), 1791–1800. https://doi.org/10.1212/WNL.
58.12.1791
Tijms, B. M., Willemse, E. A. J., Zwan, M. D., Mulder, S. D., Visser, P. J., Van
Berckel, B. N. M., … Teunissen, C. E. (2018). Unbiased approach to
counteract upward drift in cerebrospinal fluid amyloid-β 1–42 analysis
results. Clinical Chemistry, 64(3), 576–585. https://doi.org/10.1373/
clinchem.2017.281055
Timmler, S., & Simons, M. (2019). Grey matter myelination. Glia, 1–8.
https://doi.org/10.1002/glia.23614
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F.,
Etard, O., Delcroix, N., … Joliot, M. (2002). Automated anatomical
labeling of activations in SPM using a macroscopic anatomical
parcellation of the MNI MRI single-subject brain. NeuroImage, 15(1),
273–289. https://doi.org/10.1006/nimg.2001.0978
Uddin, M. N., Figley, T. D., Marrie, R. A., & Figley, C. R. (2018). Can
T1w/T2w ratio be used as a myelin-specific measure in subcortical
structures? Comparisons between FSE-based T1w/T2w ratios,
GRASE-based T1w/T2w ratios and multi-echo GRASE-based myelin
water fractions. NMR in Biomedicine, 31(3), e3868. https://doi.org/10.
1002/nbm.3868
Van Der Flier, W. M., Pijnenburg, Y. A. L., Prins, N., Lemstra, A. W.,
Bouwman, F. H., Teunissen, C. E.,… Scheltens, P. (2014). Optimizing patient
care and research: The Amsterdam dementia cohort. Journal of Alzheimer's
Disease, 41(1), 313–327. https://doi.org/10.3233/JAD-132306
Van Der Flier, W. M., & Scheltens, P. (2018). Amsterdam dementia cohort:
Performing research to optimize care. Journal of Alzheimer's Disease, 62
(3), 1091–1111. https://doi.org/10.3233/JAD-170850
Van Duijn, S., Bulk, M., Van Duinen, S. G., Nabuurs, R. J. A., Van
Buchem, M. A., Van Der Weerd, L., & Natté, R. (2017). Cortical iron
reflects severity of Alzheimer's disease. Journal of Alzheimer's Disease,
60(4), 1533–1545. https://doi.org/10.3233/JAD-161143
van Rooden, S., Versluis, M. J., Liem, M. K., Milles, J., Maier, A. B.,
Oleksik, A. M., … van der Grond, J. (2014). Cortical phase changes in
Alzheimer's disease at 7T MRI: A novel imaging marker. Alzheimer's &
Dementia, 10(1), e19–e26. https://doi.org/10.1016/j.jalz.2013.02.002
Wallace, M. N., Cronin, M. J., Bowtell, R. W., Scott, I. S., Palmer, A. R., &
Gowland, P. A. (2016). Histological basis of laminar MRI patterns in
high resolution images of fixed human auditory cortex. Frontiers in
Neuroscience, 10, 1–12. https://doi.org/10.3389/fnins.2016.00455
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014).
The role of iron in brain ageing and neurodegenerative disorders.
The Lancet Neurology, 13(10), 1045–1060. https://doi.org/10.1016/
S1474-4422(14)70117-6
Yasuno, F., Kazui, H., Morita, N., Kajimoto, K., Ihara, M., Taguchi, A., …
Nagatsuka, K. (2017). Use of T1-weighted/T2-weighted magnetic res-
onance ratio to elucidate changes due to amyloid β accumulation in
cognitively normal subjects. NeuroImage: Clinical, 13, 209–214.
https://doi.org/10.1016/j.nicl.2016.11.029
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R.
(2004). Iron, brain ageing and neurodegenerative disorders. Nature
Reviews Neuroscience, 5(11), 863–873. https://doi.org/10.1038/nrn1537
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.
How to cite this article: Pelkmans W, Dicks E, Barkhof F,
et al. Gray matter T1-w/T2-w ratios are higher in Alzheimer's
disease. Hum Brain Mapp. 2019;1–10. https://doi.org/10.
1002/hbm.24638
10 PELKMANS ET AL.
